✦ LIBER ✦

Phase II trial of edatrexate in patients with metastatic colorectal cancer

✍ Scribed by Gerald H. Clamon; Charles E. Riggs; Robert Dreicer; Raymond J. Hohl

Publisher: Springer US
Year: 1995
Tongue: English
Weight: 242 KB
Volume: 13
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluorodeoxyuridine with continuous leuco

Fluorodeoxyuridine with continuous leucovorin infusion a phase ii clinical trial in patients with metastatic colorectal cancer

✍ Robert D. Levin; John H. Gordon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Phase II trial of edatrexate in patients

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma

✍ Ephraim S. Casper; Gary K. Schwartz; Bruce Johnson; David P. Kelsen 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 293 KB

Phase II trial of edatrexate in small ce

Phase II trial of edatrexate in small cell lung cancer

✍ Martin Wiesenfeld; James R. Jett; John Q. Su; Theodore A. Braich; Carl G. Kardin 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Phase II trial of combined irinotecan an

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

✍ Paulo M. Hoff; Robert A. Wolff; Henry Xiong; Dennie Jones; Edward Lin; Cathy Eng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Phase II trial of piroxantrone in metast

Phase II trial of piroxantrone in metastatic breast cancer

✍ Peter M. Ravdin; Stephanie Green; James H. Doroshow; Silvana Martino 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 274 KB

Phase II trial of dimethyltriazenoimidaz

Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid

✍ Ronald M. Bukowski; Catherine M. Tangen; Robert F. Peterson; Thomas R. Fleming; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Background. The use of chemotherapy in patients with metastatic carcinoid tumors has been of limited value, and investigiition of new agents is necessary. Previous reports have suggested that dimethyltriazenoimidazole carboxamide (DTIC) may have antitumor activity. Methods. A Phase I1 trial to inve